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Background: Mondia whitei and Guibourtia tessmannii are used in Cameroon traditional medicine as aphrodisiacs.
The present study was undertaken to evaluate the pro-ejaculatory effects of the aqueous and organic solvent
extracts of these plants in spinal male rats.
Methods: In spinal cord transected and urethane-anesthetized rats, two electrodes where inserted into the
bulbospongiosus muscles and the ejaculatory motor pattern was recorded on a polygraph after urethral and penile
stimulations, intravenous injection of saline (0.1 ml/100 g), dopamine (0.1 μM/kg), aqueous and organic solvent
plant extracts (20 mg/kg).
Results: In all spinal rats, urethral and penile stimulations always induced the ejaculatory motor pattern. Aqueous or
hexane extract of Mondia whitei (20 mg/kg) prevented the expression of the ejaculatory motor pattern. The
pro-ejaculatory effects of dopamine (0.1 μM/kg) were not abolished in spinal rats pre-treated with Mondia whitei
extracts. Aqueous and methanolic stem bark extracts of Guibourtia tessmannii (20 mg/kg) induced fictive ejaculation
characterized by rhythmic contractions of the bulbospongiosus muscles followed sometimes with expulsion of
seminal plugs. In rats pre-treated with haloperidol (0.26 μM/kg), no ejaculatory motor pattern was recorded after
intravenous injection of Guibourtia tessmannii extracts (20 mg/kg).
Conclusion: These results show that Mondia whitei possesses preventive effects on the expression of fictive
ejaculation in spinal male rats, which is not mediated through dopaminergic pathway; on the contrary, the
pro-ejaculatory activities of Guibourtia tessmannii require the integrity of dopaminergic system to exert its effects.
The present findings further justify the ethno-medicinal claims of Mondia whitei and Guibourtia tessmannii.
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Ejaculation is the physiological process that describes
the expulsion of the semen from the urethra and com-
prises two successive phases, emission and expulsion
and requires the participation of different pelvi-perineal
anatomical structures [1-3]. The emission phase consists
of secretion of the various components of semen by
seminal vesicles, prostate and through release of ampul-
lary vasa deferentia content into the prostatic urethra.* Correspondence: pwatcho@yahoo.fr
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reproduction in any medium, provided the orThe expulsion phase corresponds to forceful propulsion
of sperm from the prostatic urethra to the urethral me-
atus through rhythmic contractions of perineal striated
muscles, with a primary role for the bulbospongiosus
muscle (BS) [4]. Ejaculation is controlled by the central
nervous system both at brain and spinal levels.
In the brain, experimental evidence suggests the
existence of a cerebral ejaculation-related subcircuit
within a larger neural circuitry involved in male sexual
behavior [5]. At the spinal level, evidence has shown
the existence of a generator that controls both phases
of ejaculation, located within the lumbosacral spinal
cord [6,7]. This ejaculation generator is under thel Ltd. This is an Open Access article distributed under the terms of the Creative
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iginal work is properly cited.
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hypothalamus [6,8].
A growing number of international studies on sexual
health issues suggest that many men worldwide have sex-
ual health problems mainly centered in the ejaculatory
function [9,10]. Particularly, premature or rapid ejacula-
tion is the most common male ejaculatory dysfunctions
and its prevalence is estimated at approximately 30%
across all age groups [11]. Many pharmaceutical drugs like
fluoxetin, paroxetin, haloperidol and serotonin have been
exploited to control ejaculatory response [12,13]; but these
compounds have significant side effects [13,14]. Several
studies have shown that medicinal plants with aphrodisiac
properties are viable alternatives with anecdotal evidence
for their effectiveness in the management of sexual disor-
ders including ejaculation dysfunctions [15-17]. Aphrodi-
siacs are substances able to excite libido or arouse sexual
instinct and can be categorized according to their mode of
action into three groups: by increasing libido (i.e. sexual
desire), by increasing potency (i.e. effectiveness of erec-
tion) and by increasing sexual pleasure [18]. These sub-
stances act at the CNS system by altering specific
neurotransmitters or sex hormone concentrations [16-21].
Aphrodisiacs mainly derived from plant species act on
specific neurotransmitter systems. For instance, previous
results from our research group have shown that an intra-
venous injection of extracts from Bersama engleriana [21]
and Dracaena arborea (unpublished) to spinal male rats
prevent the rhythmic contractions of the bulbospongiosus
muscles (the main ejaculatory muscles) and the occur-
rence of ejaculation induced by dopamine and oxytocin.
Mondia whitei (Periplocaceae) and Guibourtia tessmannii
(Caesalpiniaceae) used in the present study also belong to
this large group of aphrodisiac plants.
Mondia whitei is a woody climber with a large tu-
berous root stock; it is widely distributed in tropical
Africa, from Guinea through Cameroon to East Africa.
In Cameroon, Mondia whitei is referred to as "Limte",
"Nkang bongo", "Yang" or "la racine". The roots are used
either as spices, aphrodisiacs or for the treatment of
urinary tract infection, jaundice and headache, while the
whole plant is used to treat diarrhea [22,23]. By testing
various extracts from the roots of Mondia whitei, we
reported that the aqueous and hexane extracts induced
an androgenic effect [24,25], promoted vas deferens and
corpus cavernosum relaxation [26] and facilitated the
expression of sexual behaviour [27].
Traditional medicine reports that Guibourtia tessmannii
also referred to as ``Essingang`` or ``Bubinga`` is a tall
size tree (40-50 m) widespread throughout tropical Africa
and America and, preferring higher rainfall or evergreen
forests. This plant is distributed from Cameroon to
Democratic Republic of Congo and parts of southern
America. In the Centre Region of Cameroon, the stembarks are used for the treatment of cardiovascular diseases
[28], cancer [29] and as aphrodisiacs. To the best of our
knowledge, no work has been carried out to scientifically
justify the effects of Guibourtia tessmannii on sexual be-
havior. With the hypothesis that the bioactive compounds
present in Mondia whitei and Guibourtia tessmannii
possess an aphrodisiac effect acting upon the ejaculatory
circuitry, the present study was undertaken to evaluate the
ejaculatory properties of aqueous and organic extracts of
Mondia whitei and Guibourtia tessmannii in spinal cord
transected and urethane-anesthetized rats. We employed
the fictive ejaculation model in spinally and urethane-
anaesthetized male rats [21,30]. This model permits the
recording and visualization of the rhythmic motor pattern
of ejaculation accompanied by complex pelvic activity that
includes phasic and strong penile erections, as well as
penile movements followed by the potent expulsion of
urethral contents. The rhythmic motor pattern of ejacu-
lation registered in this experimental model is elicited
by urethral and penile stimulations and can additionally
be induced by systemic administration of several drugs
including medicinal plant extracts [3,19-21]. Growing
evidence shows that dopamine is a neurotransmitter
playing a central role in the control of ejaculation
[31,32]. Thus, for instance, stimulation of dopaminergic
receptors by systemic dopamine [21] or apomorphine
[33,34] provokes the expression of ejaculation in spinal
male rats. On the other side, systemic administration of
antagonists of dopaminergic receptors abolishes the
expression of the ejaculatory response in spinal rats
[35,36]. Accordingly, in the present study, the effects of
the plant extracts were also investigated in the presence
or absence of dopamine or its nonspecific antagonist,
haloperidol.
Methods
Collection of plant material and preparation of extracts
Mondia whitei collection
Fresh roots of Mondia whitei were collected in December
2010 in Bangangté, Nde Division, West Region, Cameroon.
Botanical identification was done at the Cameroon National
Herbarium (HNC) in Yaoundé in comparison with the
Herbarium Voucher specimen No42920/HNC. The roots
of Mondia whitei were cut into small pieces of about 1.5-




A total of 250 g of the powder of Mondia whitei roots
were macerated in 1.5 L of distilled water for 72 hours.
The macerate was filtered and the filtrate was oven dried
(55°C). The resulting material was found to weight 23 g
(9.2% yield, w/w based on the dried starting weight). The
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residue in a known volume of saline solution and the
final volume adjusted to 10 ml with the same solvent.
Hexane extract
A total of 300 g of the powder of Mondia whitei roots
were macerated in 1 L of hexane for 72 hours to yield,
after solvent evaporation under reduced pressure,
1.145 g of brownish extract corresponding to an extrac-
tion yield of 0.38% (w/w based on the dried starting
weight). The working hexane solution was obtained by
dissolving 1 g of the residue in 1 ml of tween 20 and the
final volume adjusted to 10 ml with saline solution.
Guibourtia tessmannii collection
Fresh stem barks of Guibourtia tessmannii were collected
in December 2010 in Ngoumou, Mefou-Akono Division,
Center Region, Cameroon. Botanical identification was
performed in the Cameroon National Herbarium (HNC)
in comparison with the existing Herbarium Voucher
specimen 1037/SRFCA. The stem bark was shade-dried
and powdered using an electric grinder (Moulinex).
Guibourtia tessmannii extracts
Aqueous extract
A total of 250 g of the powder of Guibourtia tessmannii
were macerated in 1.5 L of distilled water for 72 hours.
The macerate was filtered and the filtrate was oven dried
(55°C). The resulting material was found to weight
37.6 g (15.04% yield, w/w based on the dried starting
weight). The working solution was obtained by dissolv-
ing 1 g of the residue in a known volume of saline solu-
tion and the final volume adjusted to 10 ml with the
same solvent.
Methanolic extract
A total of 300 g of the powder of Guibourtia tessmannii
were macerated in 1.5 L of methanol for 72 hours to
yield, after solvent evaporation under reduced pressure,
34.1 g of brownish extract corresponding to an extrac-
tion yield of 11.37% (w/w based on the dried starting
weight).
Phytochemical screening
The aqueous and organic extracts of Mondia whitei and
Guibourtia tessmannii were screened for the presence or
absence of groups of triterpenes, reducing sugars, phe-
nolics and phytosterols using the following standard
techniques [37-40]:
Iron chloride test
This test detects the presence of phenyl compounds. In
a test tube, some drops of the plant extract are added to
methanol and then a few drops of methanol added. Thepresence of phenyl compounds is marked by the appear-
ance of a blue or violet coloration.
Liebermann-Burchard test
This test detects the presence of steroid and triterpenes.
In a test tube, some drops of the plant extract are added
to chloroform followed by a few drops of acetic anhydride
and concentrated sulfuric acid. The presence of steroids is
marked by the appearance of a greenish blue coloration
while triterpenes are revealed by a red violet coloration.
Molish test
This test detects the presence of sugars. In a test tube,
some drops of the plant extract are added to ethanol
and ethanolic alpha naphtol. After homogenization, a
few drops of concentrated sulfuric acid are equally
added. The presence of sugars is marked by the presence
of a red violet rind at the interphase.
Flavonoid test
This test detects the presence of flavonoids. In a test tube,
some drops of the plant extract are dissolved in methanol
followed by addition of a few drops of concentrated hydro-
chloric acid and powdered magnesium. The presence of fla-
vonoids is marked by the appearance of a pink, orange or
purple coloration and triterpenes by a red violet coloration.
Animals
Healthy and sexually experienced adult male Wistar rats
(> 90 days, 200–300 g body weight) were obtained from
the animal house of the Department of Animal Biology
of the University of Dschang. They were housed in
groups (four rats per cage), under natural LD cycle and
with free access to food and water. The experiments
were performed in accordance with the internationally
accepted standard ethical guidelines for laboratory animal
use and care as described in the European Community
guidelines; EEC Directive 86/609/EEC, of the 24th
November 1986 [41].
Sexual training
To provide sexual experience, each male rat was submitted
to five consecutive sexual behavioural tests with an ovar-
iectomized female brought to heat (estrus) artificially with
a single subcutaneous dose of 30 μg estradiol benzoate and
600 μg progesterone, 48 h and 6 h before testing. In ovar-
iectomized rat, it was shown that estradiol benzoate
induced a specific urge to seek contact with a sexual active
male [42]. Behavioural observations were conducted after
the onset of darkness and males were individually intro-
duced into a cylindrical observation cage and an adaptation
period (5-10 min) was allowed. Then, a receptive stimulus
female was introduced and the copulatory behaviour was
permitted during a period of 25 min. Male rats exhibiting
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than 15 min in the last three sessions were used to classify
them as sexually experienced male rats.Drugs
Dopamine, urethane, estradiol, progesterone (Sigma
Chemicals, St Louis, USA) and haloperidol (MP Biomedi-
cals, Inc, Germany) were used during this study. Dopamine,
urethane and haloperidol were freshly prepared in saline
solution. Estradiol and progesterone were dissolved in
ethanol and administered in oil. Doses of dopamine
(0.1 μM/kg) and haloperidol (0.26 μM/kg) were selected
based on previous studies (21,26). For each substance,
the volume administered intravenously was 0.2 ml/rat
while the infusion time was 5 s.Surgical preparation
Animals were urethane-anesthetized (1.5 g/kg intraperito-
neally), and by performing a surgical incision on the peri-
neum, the bulbospongiosus genital muscles were identified
and exposed. Two electrodes (EL 452, 12 mm, BIOPAC)
were inserted into the bulbospongiosus muscles to record
electromyographic (EMG) activity. For a better visualization
of the motor genital activity associated with the ejaculation,
an additional surgery was performed to expose the bulbar
portion of the penis and its anatomical connections with
the striated bulbospongiosus muscles. At the end of the
surgical approach, the spinal cord was blunt transected
around T6 spinal level and prepared for recording [19].
Treatments were administered by infusing the selected
extracts and compounds into the jugular vein.Table 1 Results of the phytochemical screening of Mondia
whitei and Guibourtia tessmannii extracts
Group of
compounds









Reducing sugars + + - -
Triterpenes + + - -
Steroids + + - -
Phenolic compounds - - + +
Flavonoid - - - -
+: present - : absent.Experimental treatment
Animals were randomly divided into 12 groups of five rats
each and intravenously treated as follows: Group 1, saline
solution or tween in saline solution (1 ml/kg, control);
Group 2, aqueous extract of Mondia whitei (20 mg/kg);
Group 3, hexane extract of Mondia whitei (20 mg/kg);
Group 4, aqueous extract of Guibourtia tessmannii
(20 mg/kg); Group 5, methanolic extract of Guibourtia
tessmannii (20 mg/kg); Group 6, dopamine (0.1 μM/kg);
Group 7, aqueous extract of Mondia whitei (20 mg/kg)
plus dopamine (0.1 μM/kg); Group 8, hexane extract of
Mondia whitei (20 mg/kg) plus dopamine (0.1 μM/kg);
Group 9, haloperidol (0.26 μM/kg); group 10, haloperidol
(0.26 μM/kg) plus methanolic extract of Guibourtia tess-
mannii (20 mg/kg). In all sequential treatments (Groups
7, 8, 10), the second drug application was performed
3 minutes after the first one. The doses of plant extracts
were chosen on the basis of our pilot studies (unpublished)
and the infusion time was 5 s.Activation and recording of the rhythmic genital motor
pattern of ejaculation
Immediately after spinal cord transection, ejaculatory
motor patterns could be reflexively expressed and recorded
in the genital muscles of all animals. To establish the
capacity of the spinal apparatus to produce the genital
rhythmic pattern after spinalization, two consecutive ejacu-
latory motor patterns were repeatedly evoked at 3-min
intervals by the injection of saline solution (200 μl/min)
through a PE-50 catheter (0.965 mm o.d.) inserted into the
pelvic urethra through a bladder incision. Injection of saline
solution was directed to increase the intraurethral pressure
to simulate the urethral distention produced by the empty-
ing of the contents of the accessory glands into the poster-
ior urethra. Thereafter, one of the selected treatments was
intravenously applied and the number, frequency of
contractions of the striated bulbospongiosus muscles and
its latency of response obtained under their influence were
recorded for 5 min, which was registered on a polygraph
(Biopac Student Lab PRO, version 3.7.3, frequency 50Hz
and model MP36E-CE).
Five minutes after recording the EMG in each sequen-
tial treatment, three consecutive urethral stimulations
were monitored at 3 min intervals, as described above.
The latency of contractions was expressed as the time
elapsed from the application of a test stimulus until the
first contraction of the bulbospongiosus muscles. The
number of motor contractions included all motor con-
tractions expressed in the motor ejaculatory train evoked
by the sensorial or pharmacological stimuli. The fre-
quency of contractions of the bulbospongiosus muscles
was calculated by dividing the number of contractions
by the duration of the motor train.
Statistical analysis
Data are reported as the mean plus standard error of
mean (SEM). Significance was calculated by one-way ana-
lysis of variance (ANOVA) followed with post-hoc Tukey
HSD test for multiple comparisons. p values < 0.05 were
considered significant. The statistical tests were performed
with Stat Soft, Inc. (2008). STATISTICA (data analyses
software system), version 8.0.www.statsoft.com.
A B
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Figure 1 Polygraphic EMG tracings showing the effects of
mechanical and pharmacological stimulations upon the
expression of the fictive ejaculation response in spinal rats: (A)
Urethral stimulation; (B) Penile stimulation; (C) Intravenous
injection of saline solution. Arrows indicate the moment of injection.
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Phytochemical screening
Phytochemical screening of the aqueous and hexane
extracts of Mondia whitei showed reducing sugars, tri-
terpenes and steroids while phenolic compounds were
found in Guibourtia tessmannii extracts (Table 1).
Activation of the ejaculatory motor response by urethral
and penile stimulations
In all spinal cord transected and urethane-anesthetized
rats, injection of saline solution (200 μl/min) into the
pelvic urethra (urethral stimulation) before each drug
administration provoked rapid rhythmic contractions of
the striated bulbospongiosus muscles with an average
mean of 4.57 ± 0.81 contractions (Figure 1A and Table 2).
In some cases, an expulsion of the urethral contents
accompanied the ejaculatory rhythmic contractions and
was always accompanied by penile movements and
penile erections. Penile stimulation also provoked theTable 2 Effects of urethral and penile stimulations, intraveno





Dopamine (0.1 μM/kg) 9.80 ±
Aqueous extract of Guibourtia tessmannii 20 mg/kg 4.80 ±
Methanolic extract of Guibourtia tessmannii 20 mg/kg 3.80 ±
Aqueous extract of Mondia whitei (20 mg/kg) plus dopamine
(0.1 μM/kg)
6.66
Hexane extract of Mondia whitei (20 mg/kg) plus dopamine
(0.1 μM/kg)
6.67
Number of rats per group = 5. All values are expressed as mean ± SEM. Urethral and
stimulations carried out in this study (three stimulations per rat).
### p < 0.001 significantly different compared with urethral stimulation.
Ф p < 0.05, ФФ p < 0.01 and ФФФ p < 0.001significantly different compared with penil
*p < 0.05, **p < 0.01 and *** p < 0.001 significantly different compared with dopamin
For each rat, the frequency of contractions of the bulbospongiosus muscles was ca
motor train and the latency was observed during EMG recording. ND = not determrhythmic ejaculatory pattern with an average mean of
8.52 ± 1.59 contractions (Figure 1B and Table 2). Penile
stimulation appeared to be more efficient than urethral
stimulation to provoke rapid response (latency of con-
tractions: 2.53 ± 0.8 s). Intravenous administration of
saline solution or tween in saline solution (not shown)
did not provoke fictive ejaculation (Figure 1C, and
Table 2).
Activation of the ejaculatory motor response by
dopamine and haloperidol administration
Dopamine (0.1 μM/kg) administration provoked the
rhythmic ejaculatory pattern with an average mean of
9.80 ± 0.86 contractions (Figure 2A, and Table 2) corre-
sponding to an ejaculatory latency of 11.89 ± 2.35 s. Intra-
venous administration of haloperidol (0.26 μM/kg), a
nonspecific antagonist dopamine receptor, resulted in no
contraction of the bulbospongiosus muscles (Figure 2B,
and Table 3).
Effects of Mondia whitei and Guibourtia tessmannii
extracts on fictive ejaculation
Intravenous administration of either the aqueous extract
(20 mg/kg) or the hexane extract (20 mg/kg) of Mondia
whitei in spinal cord transected and urethane-anesthetized
rats did not provoke the activation of the ejaculatory
motor pattern. These effects were similar to those
obtained after intravenous saline injection (0.1 ml per
100 g of bw) (Figure 3A, B, and Table 3) or tween in saline
solution (not shown). On the other hand, the aqueous and
methanolic extracts of Guibourtia tessmannii (20 mg/kg)
induced fictive ejaculation, characterized by rhythmic con-
traction of the bulbospongiosus muscles and followed








± 0.81 0.45 ± 0.03 28.11 ± 5.65
± 1.59 0.34 ± 0.05 2.53 ± 0.80
0.86### 0.41 ± 0.02 11.89 ± 2.35###,ФФФ
1.15Ф,*** 0.38 ± 0.05 284.02 ± 75.10###,ФФФ,***
0.93ФФ,*** 0.38 ± 0.04 150.86 ± 36.98###,ФФФ,***
± 0.66 0.48 ± 0.06 ND
± 0.89 0.46 ± 0.02 ND
penile stimulations represent the mean value of all urethral and penile
e stimulation.
e.
lculated by dividing the number of contractions (N) by the duration of the
ined.
A B
Figure 2 Polygraphic EMG tracings showing the effects of
mechanical and pharmacological stimulations upon the
expression of the fictive ejaculation response in spinal rats: (A)
Intravenous injection of dopamine (0.1 μM/kg); (B) Intravenous
injection of haloperidol (0.26 μM/kg) (first arrow) followed by
the injection of dopamine (0.1 μM/kg) (second arrow). Arrows
indicate the moment of injection.
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contractions appeared with a significant delay when com-
pared to dopamine (p < 0.001).Effects of the aqueous and hexane extracts of Mondia
whitei on the expression of dopamine-induced fictive
ejaculation
The evidence that dopamine (0.1 μM/kg) induced fictive
ejaculation was shown in Figure 2A and Table 2. This
pro-ejaculatory effect of dopamine was not prevented in
rats pre-treated with Mondia whitei extracts (20 mg/kg)
(Figure 4A, B, and Table 3).Effects of haloperidol on the expression of Guibourtia
tessmannii-induced fictive ejaculation
Pre-treated rats with haloperidol, a non-specific antag-
onist of dopamine receptors, prevented the Guirboutia
tessmannii methanolic extract-induced expression of
EMG activity of the bulbospongiosus muscles in all rats
(Figure 5A, B, and Table 3).Table 3 Effects of intravenous administration of drugs on the
Treatment
Saline solution (0.9%) (0.1 ml/kg)
Dopamine (0.1 μM/kg)
Haloperidol (0.26 μM/kg)
Aqueous extract of Mondia whitei, 20 mg/kg
Aqueous extract of Mondia whitei (20 mg/kg) plus dopamine (0.1 μM/kg)
Hexane extract of Mondia whitei, 20 mg/kg
Hexane extract of Mondia whitei (20 mg/kg) plus dopamine (0.1 μM/kg)
Aqueous extract of Guibourtia tessmannii, 20 mg/kg
Methanolic extract of Guibourtia tessmannii, 20 mg/kg
Haloperidol (0.26 μM/kg) plus methanolic extract of Guibourtia tessmannii (20
Number of rats per group = 5. + = present - = absent.Discussion
In the present study, we observed that the fictive ejacu-
lation response was prevented after the intravenous
administration of the aqueous and hexane extracts of
Mondia whitei (20 mg/kg) and facilitated after systemic
injection of Guibourtia tessmannii (20 mg/kg) extracts.
Data obtained with Mondia whitei show that the bio-
active compounds present in this medicinal plant exert a
delaying effect at the level of the spinal cord to block the
expression of the ejaculatory motor pattern. However,
when compared to the androgenic and pro-sexual poten-
tials of Mondia whitei shown in male rats [24,27], it
could clearly be proposed that the crude extracts from
this plant act at different levels to promote male sexual
potency and fertility. In agreement with Sandroni [18],
substances that increase sexual potency are considered
as aphrodisiac compounds [27,43] and its influence is
directly observed on male sexual reflexes, including
ejaculation. Present findings in spinal male rats show
that the aphrodisiac effects of Mondia whitei previously
reported in copulating male rats [27] may not be
promoted by an increase in sexual potency. Thus, it
seems that the compounds contained in Mondia whitei
extracts act differentially on various structures of the
central nervous system involved in the expression of
ejaculation by exerting a facilitatory pro-sexual effect on
brain structures or by exerting inhibitory effects on
spinal circuits. In an attempt to determine the possible
targets and mechanism(s) of action of Mondia whitei in
the delay of ejaculation observed in the present work,
the ejaculation-preventing effects of Mondia whitei were
evaluated on dopamine-induced ejaculation in spinalized
animals. Thus, the pro-ejaculatory effect of dopamine
(0.1 μM/kg) was not abolished in spinal rats pre-treated
with Mondia whitei extracts. It could therefore be
thought that Mondia whitei possesses preventive effects













Figure 5 Polygraphic EMG tracings showing the inhibiting
effects of haloperidol on the aqueous (A) and methanolic (B)
extracts of Guibourtia tessmannii-induced fictive ejaculation.
Long and thick arrows indicate haloperidol injection while short and
thin arrows show Guibourtia tessmannii injection.
A B
C D
Figure 3 Polygraphic EMG tracings showing the effects of plant
extracts: (A) Aqueous extract of Mondia whitei (20 mg/kg); (B)
Hexane extract of Mondia whitei (20 mg/kg); (C) Aqueous
extract of Guibourtia tessmannii (20 mg/kg); (D) Methanolic
extract of Guibourtia tessmannii (20 mg/kg). Arrows indicate the
moment of injection.
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In copulating male rats, it has been shown that Mondia
whitei exerts its aphrodisiac effects by acting upon the
dopaminergic system but the precise site of action is not
known at present [27]. Present data suggest that the
preventing actions of Mondia whitei on the expression
of ejaculatory response are not exerted at the level of the
spinal circuits that structure the ejaculation generator
but instead, a main role for higher nervous structures in
the mediation of its aphrodisiac actions can be sug-
gested. Present finding further suggests that Mondia
whitei could be a good candidate for patients with rapid
ejaculation in order to prevent the prompt expression of
ejaculation.
It was observed in the present work that Guibourtia
tessmannii extracts can facilitate ejaculatory response in
male rats and therefore give a first account for the
claimed pro-sexual properties of this plant. The aqueous
and methanolic stem bark extracts of Guibourtia
tessmannii-induced fictive ejaculation was characterized
by rhythmic contraction of the bulbospongiosus mus-
cles, followed sometimes with the expulsion of seminal
plugs and by a significant increase in its latency of
expression. This significantly long latency promoted by
Guibourtia tessmannii extracts suggests that the aphro-
disiac potentials of the plant may be related to theA B 
Figure 4 Polygraphic EMG tracings showing the effects of
sequential treatment of Mondia whitei plus dopamine; (A)
Aqueous extract of Mondia whitei (20 mg/kg) plus dopamine
(0.1 μM/kg); (B) Hexane extract of Mondia whitei (20 mg/kg) plus
dopamine (0.1 μM/kg). Long and thick arrows indicate plant extract
injection while short and thin arrows show dopamine injection.promotion of sexual potency [18] i.e. the promotion of
the ejaculatory motor trains. As occurred with other
previously reported aphrodisiac plant extracts [19,20],
it seems that the compounds contained in the aqueous
and methanolic extracts of Guibourtia tessmannii
exert their actions by targeting the spinal circuits in
charge of ejaculation control.
Besides, a pre-treatment of rats with haloperidol
(0.26 μM/kg), a non-specific antagonist for all dopamine
receptors, completely abolished the aphrodisiac effect of
Guibourtia tessmannii. These results denote the partici-
pation of the spinal dopaminergic pathways. In line with
the present results, it has been found that some plant
extracts with aphrodisiac actions such as Bersama
engleriana [21] prolong the ejaculatory latency and
the occurrence of fictive ejaculation induced by dopa-
mine through the blockade of dopaminergic receptors
in rats. Thus, it appears that the dopaminergic system
plays a main potential role in the mediation of the
pro-sexual actions evoked by aphrodisiac plants and
further supports the notion that the presumed dopa-
minergic receptors that are targeted by Guibourtia
tessmannii are located on the neurons of the ejacula-
tion generator. Specific studies are necessary to test
these possibilities.
Fictive ejaculation is a physiological response regis-
tered in urethane-anaesthetized and spinal rats charac-
terized by the rhythmic contractions of bulbospongiosus
muscles [30]. It has been demonstrated that fictive
ejaculation can be pharmacologically induced by the sys-
temic injection of dopamine or apomorphine acting at
the spinal generator for ejaculation [21,33,34,44] and it
has been considered as the main model for the study of
the spinal pattern generator of ejaculation [8]. Thus,
with no doubt, the effect of the aphrodisiac plants could
be systemically evaluated by using the fictive ejaculation
model and particular results, highlight the differential
effects of aphrodisiac plants.
Conclusion
Present results show that Mondia whitei extracts could
be considered as an ejaculation blocking agent that
prevents the expression of fictive ejaculation, an effect
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On the other hand, Guibourtia tessmannii-induced
fictive ejaculation requires principally the integrity of
the dopaminergic system. Further investigation of the
effects of these two medicinal plants in animals with real
ejaculatory dysfunction such as diabetic or obese rats is
highly needed.
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